Prior Auth Required

0424U - molecular evidence, low-, moderate- or elevated-risk of prostate cancer

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Servicemolecular evidence, low-, moderate- or elevated-risk of prostate cancer
Procedure / Service Description

Oncology (pan-solid tumor), analysis of DNA biomarker response to anti-cancer therapy using - Oncology (prostate), exosome-based analysis of 53 small noncoding RNAs (sncRNAs) by quantitative reverse transcription polymerase chain reaction (RT-qPCR), urine, reported as no 0424U molecular evidence, low-, moderate- or elevated-risk of prostate cancer Insertion or replacement of neurostimulator system for treatment of central sleep apnea; 0425T sensing lead only

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.